Whey protein may have an influence on lowering blood pressure, according to research published in the upcoming November issue of International Dairy Journal.In a six-week controlled intervention, researchers at Washington State University tested the effects of daily consumption of 28 g of hydrolyzed or non-hydrolyzed whey protein beverages on young men and women.
Whey protein may have an influence on lowering blood pressure, according to research published in the upcoming November issue of International Dairy Journal.
In a six-week controlled intervention, researchers at Washington State University tested the effects of daily consumption of 28 g of hydrolyzed or non-hydrolyzed whey protein beverages on young men and women.
Systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial blood pressure (MAP) were measured.
Comparing hydrolyzed to non-hydrolyzed whey, no differences on influencing the above measures were noted; but the influence of both wheys on blood pressure markers was often significant. In subjects with elevated SBP and DBP, whey significantly decreased these measures. In subjects with high SBP only, whey significantly decreased this measure. For subjects with healthy blood pressure levels, SBP, DBP, and MAP remained unchanged after baseline.
Total and low-density lipoprotein (LDL or 'bad'ÃÂ cholesterol) was also lowered in subjects after whey consumption.
The results of this intervention left researchers to conclude that 'Whey protein beverages may be useful for the dietary treatment of prehypertension and/or stage 1 hypertension.'ÃÂ
To read the study abstract, click here.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.